Approvals/TGA/IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Approved

STANDARD

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Eugia Pharma (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d817de88ced6ac97
Product Name: IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Artg Id: 439210
Artg Name: IRINOTECAN EPSL irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Sponsor: Eugia Pharma (Australia) Pty Ltd
Company Detail Path: /organization/eugia-pharma-australia-pty-ltd
Artg Date: 2025-03-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d817de88ced6ac97

Type

Standard